This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Hypertension
and you are
between 19 and 50
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

An Open-label, Fixed-sequence, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety after multiple oral doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects.

Provided treatments

  • Drug: Fimasartan
  • Drug: Amlodipine
  • Drug: Rosuvastatin
Tris trial is registered with FDA with number: NCT02397538. The sponsor of the trial is Boryung Pharmaceutical Co., Ltd and it is looking for 50 volunteers for the current phase.
Official trial title:
An Open-label, Fixed-sequence, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects